- Home
- WST vs LI Comparison
WST vs LI Comparison
Compare WST & LI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WST | LI |
|---|---|---|
| Founded | 1923 | 2015 |
| Country | United States | China |
| Employees | N/A | 30728 |
| Industry | Medical/Dental Instruments | Auto Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.6B | 13.4B |
| IPO Year | 2004 | N/A |
Fundamental Metrics
Financial Performance| Metric | WST | LI |
|---|---|---|
| Price | $353.95 | $12.95 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 7 | 10 |
| Target Price | ★ $325.86 | $19.66 |
| AVG Volume (30 Days) | 661.9K | ★ 3.5M |
| Earning Date | 04-23-2026 | 05-28-2026 |
| Dividend Yield | ★ 0.30% | N/A |
| EPS Growth | ★ 1.49 | N/A |
| EPS | ★ 4.07 | N/A |
| Revenue | ★ $2,886,900,000.00 | N/A |
| Revenue This Year | $6.76 | $18.98 |
| Revenue Next Year | $6.22 | $22.72 |
| P/E Ratio | $85.55 | ★ $29.50 |
| Revenue Growth | ★ 1.95 | N/A |
| 52 Week Low | $223.83 | $11.65 |
| 52 Week High | $386.00 | $26.94 |
Technical Indicators
Market Signals| Indicator | WST | LI |
|---|---|---|
| Relative Strength Index (RSI) | 52.21 | 46.77 |
| Support Level | $323.60 | $11.86 |
| Resistance Level | $367.66 | $13.16 |
| Average True Range (ATR) | 11.24 | 0.34 |
| MACD | -0.59 | 0.08 |
| Stochastic Oscillator | 37.72 | 31.82 |
Price Performance
Historical ComparisonAbout WST West Pharmaceutical Services Inc.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
About LI Li Auto Inc.
Li Auto is one of China's leading new energy vehicle manufacturers. Founded in 2015, the company designs, develops, manufactures, and sells premium smart NEVs with a particular focus on family size premium SUVs and MPVs. Li Auto started volume production of its first model—the Li One, an SUV that is a premium plug-in electric vehicle- in November 2019. Besides PHEVs, its product portfolio now extends to EVs that are fully battery-powered, reaching a wide audience. It has sold over 400,000 NEVs in 2025, accounting for about 3% of China's passenger NEV market.